These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36618943)

  • 1. A case report of severe pirimiphos-methyl intoxication: Clinical findings and cholinesterase status.
    Zellner T; Rabe C; von der Wellen-Pawlowski J; Hansen D; John H; Worek F; Eyer F
    Front Pharmacol; 2022; 13():1102160. PubMed ID: 36618943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholinesterase status, pharmacokinetics and laboratory findings during obidoxime therapy in organophosphate poisoned patients.
    Thiermann H; Mast U; Klimmek R; Eyer P; Hibler A; Pfab R; Felgenhauer N; Zilker T
    Hum Exp Toxicol; 1997 Aug; 16(8):473-80. PubMed ID: 9292288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human parathion poisoning. A toxicokinetic analysis.
    Eyer F; Meischner V; Kiderlen D; Thiermann H; Worek F; Haberkorn M; Felgenhauer N; Zilker T; Eyer P
    Toxicol Rev; 2003; 22(3):143-63. PubMed ID: 15181664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of reactivation test in anaesthetized dogs with experimental intoxication with nerve agents.
    Bajgar J; Fusek J; Bartosova L; Jun D; Kuca K
    J Appl Toxicol; 2006; 26(5):439-43. PubMed ID: 16915560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repetitive obidoxime treatment induced increase of red blood cell acetylcholinesterase activity even in a late phase of a severe methamidophos poisoning: A case report.
    Steinritz D; Eyer F; Worek F; Thiermann H; John H
    Toxicol Lett; 2016 Feb; 244():121-123. PubMed ID: 26200596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obidoxime in acute organophosphate poisoning: 2 - PK/PD relationships.
    Thiermann H; Worek F; Eyer P; Eyer F; Felgenhauer N; Zilker T
    Clin Toxicol (Phila); 2009 Sep; 47(8):807-13. PubMed ID: 19778190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pro: Oximes should be used routinely in organophosphate poisoning.
    Thiermann H; Worek F
    Br J Clin Pharmacol; 2022 Dec; 88(12):5064-5069. PubMed ID: 35023196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring of neuromuscular transmission in organophosphate pesticide-poisoned patients.
    Thiermann H; Zilker T; Eyer F; Felgenhauer N; Eyer P; Worek F
    Toxicol Lett; 2009 Dec; 191(2-3):297-304. PubMed ID: 19793545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of oximes in the management of organophosphorus pesticide poisoning.
    Eyer P
    Toxicol Rev; 2003; 22(3):165-90. PubMed ID: 15181665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obidoxime in acute organophosphate poisoning: 1 - clinical effectiveness.
    Eyer F; Worek F; Eyer P; Felgenhauer N; Haberkorn M; Zilker T; Thiermann H
    Clin Toxicol (Phila); 2009 Sep; 47(8):798-806. PubMed ID: 19778163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe organophosphate (demeton-S-methyl) poisoning in a two-year-old child.
    Rolfsjord LB; Fjaerli HO; Meidel N; Stromme JH; Kowalczyk M; Jacobsen D
    Vet Hum Toxicol; 1998 Aug; 40(4):222-4. PubMed ID: 9682409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro ability of currently available oximes to reactivate organophosphate pesticide-inhibited human acetylcholinesterase and butyrylcholinesterase.
    Jun D; Musilova L; Musilek K; Kuca K
    Int J Mol Sci; 2011; 12(3):2077-87. PubMed ID: 21673941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Poisoning with organophosphate compounds].
    Vos EM; Hens JJ; Lau HS; Boon ES; Bartelink AK
    Ned Tijdschr Geneeskd; 2002 Jan; 146(1):34-7. PubMed ID: 11802337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis.
    Aurbek N; Thiermann H; Eyer F; Eyer P; Worek F
    Toxicology; 2009 May; 259(3):133-9. PubMed ID: 19428953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudocatalytic scavenging of the nerve agent VX with human blood components and the oximes obidoxime and HI-6.
    Wille T; von der Wellen J; Thiermann H; Worek F
    Arch Toxicol; 2017 Mar; 91(3):1309-1318. PubMed ID: 27358236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzyme-kinetic investigation of different sarin analogues reacting with human acetylcholinesterase and butyrylcholinesterase.
    Bartling A; Worek F; Szinicz L; Thiermann H
    Toxicology; 2007 Apr; 233(1-3):166-72. PubMed ID: 16904809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of human plasma on the reactivation of sarin-inhibited human erythrocyte acetylcholinesterase.
    Worek F; Eyer P; Kiderlen D; Thiermann H; Szinicz L
    Arch Toxicol; 2000 Mar; 74(1):21-6. PubMed ID: 10817663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modern strategies in therapy of organophosphate poisoning.
    Thiermann H; Szinicz L; Eyer F; Worek F; Eyer P; Felgenhauer N; Zilker T
    Toxicol Lett; 1999 Jun; 107(1-3):233-9. PubMed ID: 10414801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Butyrylcholinesterase activity-biomarker for predicting the outcome in acute cholinesterase inhibitor poisoning--a 30-year retrospective analysis.
    Gazzi EN; Sorodoc V; Petris O; Tarţău L; Dumitrescu G; Sorodoc L; Lupuşoru CE
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(4):971-8. PubMed ID: 25581956
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.